Deep resequencing of the voltage-gated potassium channel subunit KCNE3 gene in chronic tinnitus

Behavioral and Brain Functions

Volumn 7, Issue , 2011, Pages

  Sand, Philipp G ^a   Langguth, Berthold ^a   Kleinjung, Tobias ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ARTICLE; CAUCASIAN; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; KCNE3 GENE; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; OUTPATIENT; PRIORITY JOURNAL; TINNITUS;

ADULT; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN SUBUNITS; SEQUENCE ANALYSIS, DNA; TINNITUS;

EID: 80052603233     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-7-39     Document Type: Article

References (39)

1. Moller AR. Tinnitus: presence and future. Prog Brain Res 2007, 166:3-16.
2. Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among US adults. Am J Med 2010, 123:711-718. 10.1016/j.amjmed.2010.02.015, 20670725.
3. Quantification of the burden of disease for tinnitus caused by community noise. Background paper. , http://www.chuq.qc.ca/oms/pdf/TinnitusBackgroundPaper2005.pdf
4. Bárány R. Die Beeinflussung des Ohrensausens durch intravenös injizierte Lokalanästhetika. Acta Oto-Laryngologica 1936, 23:201-203.
5. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997, 15:186-189.
6. Tyson J, Tranebjaerg L, Bellman S, Wren C, Taylor JF, Bathen J, Aslaksen B, Sorland SJ, Lund O, Malcolm S, et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997, 6:2179-2185. 10.1093/hmg/6.12.2179, 9328483.
7. Coucke PJ, Van Hauwe P, Kelley PM, Kunst H, Schatteman I, Van Velzen D, Meyers J, Ensink RJ, Verstreken M, Declau F, et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999, 8:1321-1328. 10.1093/hmg/8.7.1321, 10369879.
8. Sala-Rabanal M, Kucheryavykh LY, Skatchkov SN, Eaton MJ, Nichols CG. Molecular mechanisms of EAST/SeSAME syndrome mutations in Kir4.1 (KCNJ10). J Biol Chem 2010, 285:36040-36048. 10.1074/jbc.M110.163170, 20807765.
9. Doi K, Sato T, Kuramasu T, Hibino H, Kitahara T, Horii A, Matsushiro N, Fuse Y, Kubo T. Meniere's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec 2005, 67:289-293. 10.1159/000089410, 16374062.
10. Van Laer L, Carlsson PI, Ottschytsch N, Bondeson ML, Konings A, Vandevelde A, Dieltjens N, Fransen E, Snyders D, Borg E, et al. The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss. Hum Mutat 2006, 27:786-795. 10.1002/humu.20360, 16823764.
11. Pawelczyk M, Van Laer L, Fransen E, Rajkowska E, Konings A, Carlsson PI, Borg E, Van Camp G, Sliwinska-Kowalska M. Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise-induced hearing loss. Ann Hum Genet 2009, 73:411-421. 10.1111/j.1469-1809.2009.00521.x, 19523148.
12. Van Eyken E, Van Laer L, Fransen E, Topsakal V, Lemkens N, Laureys W, Nelissen N, Vandevelde A, Wienker T, Van De Heyning P, Van Camp G. KCNQ4: a gene for age-related hearing impairment?. Hum Mutat 2006, 27:1007-1016. 10.1002/humu.20375, 16917933.
13. Sand P, Luettich A, Kleinjung T, Langguth B. An examination of kcne1 mutations and common variants in chronic tinnitus. Genes 2010, 1:23-27.
14. de Castro MP, Aranega A, Franco D. Protein distribution of Kcnq1, Kcnh2, and Kcne3 potassium channel subunits during mouse embryonic development. Anat Rec A Discov Mol Cell Evol Biol 2006, 288:304-315.
15. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 2001, 104:217-231. 10.1016/S0092-8674(01)00207-0, 11207363.
16. McCrossan ZA, Lewis A, Panaghie G, Jordan PN, Christini DJ, Lerner DJ, Abbott GW. MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain. J Neurosci 2003, 23:8077-8091.
17. Clancy SM, Chen B, Bertaso F, Mamet J, Jegla T. KCNE1 and KCNE3 beta-subunits regulate membrane surface expression of Kv12.2 K(+) channels in vitro and form a tripartite complex in vivo. PLoS One 2009, 4:e6330. 10.1371/journal.pone.0006330, 2710002, 19623261.
18. Tlili A, Masmoudi S, Dhouib H, Bouaziz S, Rebeh IB, Chouchen J, Turki K, Benzina Z, Charfedine I, Drira M, Ayadi H. Localization of a novel autosomal recessive non-syndromic hearing impairment locus DFNB63 to chromosome 11q13.3-q13.4. Ann Hum Genet 2007, 71:271-275. 10.1111/j.1469-1809.2006.00337.x, 17166180.
19. Axelsson A, Sandh A. Tinnitus in noise-induced hearing loss. Br J Audiol 1985, 19:271-276. 10.3109/03005368509078983, 4074979.
20. Hamid MA. Meniere's disease. Pract Neurol 2009, 9:157-162. 10.1136/jnnp.2009.176602, 19448058.
21. Goebel G, Hiller W. [The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire]. HNO 1994, 42:166-172.
22. Campbell CA, Della Santina CC, Meyer NC, Smith NB, Myrie OA, Stone EM, Fukushima K, Califano J, Carey JP, Hansen MR, et al. Polymorphisms in KCNE1 or KCNE3 are not associated with Meniere disease in the Caucasian population. Am J Med Genet A 2010, 152A:67-74. 10.1002/ajmg.a.33114, 20034061.
23. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 2002, 87:4881-4884. 10.1210/jc.2002-020698, 12414843.
24. Sternberg D, Tabti N, Fournier E, Hainque B, Fontaine B. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 2003, 61:857-859.
25. Jurkat-Rott K, Lehmann-Horn F. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation. Neurology 2004, 62:1012-1015.
26. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005, 15:1034-1050. 10.1101/gr.3715005, 1182216, 16024819.
27. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, Roskin KM, Baertsch R, Rosenbloom K, Clawson H, Green ED, et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 2004, 14:708-715. 10.1101/gr.1933104, 383317, 15060014.
28. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA, Diekhans M, Smith KE, Rosenbloom KR, Raney BJ, et al. The UCSC Genome Browser database: update 2010. Nucleic Acids Res 2010, 38:D613-619. 10.1093/nar/gkp939, 2808870, 19906737.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
30. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11:116-128. 10.1016/0197-2456(90)90005-M, 2161310.
31. Ohno S, Toyoda F, Zankov DP, Yoshida H, Makiyama T, Tsuji K, Honda T, Obayashi K, Ueyama H, Shimizu W, et al. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum Mutat 2009, 30:557-563. 10.1002/humu.20834, 19306396.
32. Lundby A, Ravn LS, Svendsen JH, Hauns S, Olesen SP, Schmitt N. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008, 21:47-54. 10.1159/000113746, 18209471.
33. Zhang DF, Liang B, Lin J, Liu B, Zhou QS, Yang YQ. [KCNE3 R53H substitution in familial atrial fibrillation]. Chin Med J (Engl) 2005, 118:1735-1738.
34. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Hofman-Bang J, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008, 1:209-218. 10.1161/CIRCEP.107.748103, 2585750, 19122847.
35. Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, McManis P, Griggs RC, Angelini C, Servidei S, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 2004, 63:1647-1655.
36. Wang W, Jiang L, Ye L, Zhu N, Su T, Guan L, Li X, Ning G. Mutation screening in Chinese hypokalemic periodic paralysis patients. Mol Genet Metab 2006, 87:359-363. 10.1016/j.ymgme.2005.10.020, 16386935.
37. Trellakis S, Benzenberg D, Urban BW, Friederich P. Differential lidocaine sensitivity of human voltage-gated potassium channels relevant to the auditory system. Otol Neurotol 2006, 27:117-123. 10.1097/01.mao.0000186443.11832.8a, 16371858.
38. Lin MT, Wu MH, Chang CC, Chiu SN, Theriault O, Huang H, Christe G, Ficker E, Chahine M. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. Heart Rhythm 2008, 5:1567-1574. 10.1016/j.hrthm.2008.08.010, 18848812.
39. Danielsson BR, Lansdell K, Patmore L, Tomson T. Phenytoin and phenobarbital inhibit human HERG potassium channels. Epilepsy Res 2003, 55:147-157. 10.1016/S0920-1211(03)00119-0, 12948624.